Devin Clinton, Chong Paul Y, Holt Ginger E, Feurer Irene, Gonzalez Adriana, Merchant Nipun, Schwartz Herbert S
Department of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232-8774, USA.
J Surg Oncol. 2006 Sep 1;94(3):203-11. doi: 10.1002/jso.20477.
Sacral amputations above the S2 body often involve increased surgical complexity leading to long-term morbidity. The purpose of this study was to determine whether proximal sacral amputations have substantially higher perioperative morbidity compared with more distal sacral amputations.
We evaluated the effect of sacral amputation level on perioperative outcomes within 90 days of surgery. Outcome measures included blood loss, intensive care unit (ICU) and hospital stay, hospital cost, and incidence of a major and minor morbidity. Survival analyses were adjusted for the level of resection and histological appearance.
Thirteen proximal and 14 distal resections were performed. In comparing proximal versus distal resections, median estimated blood loss was 4 L versus 1 L (P < 0.001), ICU stay was 4 days versus 0 days (P = 0.012), hospital stay was 19 days versus 8 days (P = 0.001), hospital cost was 28,800 dollars versus 7,500 dollars (P = 0.003), with one or more major complications in 85% versus 29% (P = 0.011). Survival analysis demonstrated that the sacral resection level did not influence survival (P = 0.936), whereas the type of tumor did influence survival (P = 0.012).
Tumor resections above S2 demonstrate increased perioperative morbidity, suggesting that proximal osteotomies be reserved for patients with a realistic cure potential.
S2椎体以上的骶骨截肢术通常会增加手术复杂性,导致长期发病。本研究的目的是确定与更低位的骶骨截肢术相比,高位骶骨截肢术的围手术期发病率是否显著更高。
我们评估了骶骨截肢水平对手术90天内围手术期结局的影响。结局指标包括失血量、重症监护病房(ICU)住院时间和住院时间、住院费用以及严重和轻微并发症的发生率。生存分析根据切除水平和组织学表现进行了调整。
进行了13例高位切除和14例低位切除。比较高位切除与低位切除,估计中位失血量分别为4升和1升(P < 0.001),ICU住院时间分别为4天和0天(P = 0.012),住院时间分别为19天和8天(P = 0.001),住院费用分别为28,800美元和7,500美元(P = 0.003),发生一种或多种严重并发症的比例分别为85%和29%(P = 0.011)。生存分析表明,骶骨切除水平不影响生存率(P = 0.936),而肿瘤类型影响生存率(P = 0.012)。
S2以上的肿瘤切除术显示围手术期发病率增加,这表明高位截骨术应仅用于有实际治愈可能的患者。